Skip to main content

Featured

Zelensky Urges Stronger U.S. Pressure After Strikes Freeze Kyiv

  People take shelter inside a metro station during a Russian missile and drone attack, in Kyiv. Ukrainian President Volodymyr Zelensky is calling for intensified U.S. pressure on Russia after a new wave of missile and drone strikes left parts of Kyiv without heat, electricity, and water. The attacks, which targeted critical infrastructure during freezing winter temperatures, plunged several districts into darkness and disrupted essential services. Emergency crews worked through the night to contain fires and restore power, while city officials warned residents to brace for further outages. The strikes are part of Russia’s ongoing campaign against Ukraine’s energy grid, a strategy that has repeatedly exposed civilians to dangerous winter conditions. Zelensky urged Washington and other Western partners to respond with a unified and forceful message to Moscow, arguing that only increased diplomatic and economic pressure can deter further attacks. He emphasized that the latest stri...

article

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Comments